Status:
COMPLETED
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-004)
Lead Sponsor:
Sirion Therapeutics, Inc.
Conditions:
Inflammation
Eligibility:
All Genders
2+ years
Phase:
PHASE3
Brief Summary
The purpose of this phase III study is to determine the safety and efficacy of difluprednate in the treatment of inflammation following ocular surgery.
Eligibility Criteria
Inclusion
- Scheduled for unilateral ocular surgery.
Exclusion
- Systemic administration of any corticosteroid or immunosuppressive drug in the 2 weeks prior to study enrollment.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2008
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00616993
Start Date
January 1 2008
End Date
March 1 2008
Last Update
July 1 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eye Associates of Fort Myers
Fort Myers, Florida, United States, 33901